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INTRODUCTION
Maternal serum prenatal quadruple screening includes
tests for alpha-fetoprotein (AFP), human chorionic gona-
dotrophin (hCG), unconjugated estriol (uE3), and dimeric
inhibin A (DIA). Measurements of maternal serum AFP,
uE3, and hCG, as well as maternal age, are widely used in
the second trimester for the identification of pregnancies
at high risk of Down syndrome [1, 2]. The maternal serum
mid-trimester triple marker test is also a widely accepted
protocol in Korea [3-5]. The triple test (AFP, uE3, hCG) is
known to have a 71.3% sensitivity at a 5% false-positive
rate. However, when the gestational age is established by
ultrasound, the quadruple test (AFP, uE3, hCG, DIA) has
been demonstrated to have a better sensitivity of 77.5% at
a 5% false-positive rate [6-8]. Many platforms are com-
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mercially available for triple tests; however, DIA currently
has only two platforms-either ELISA (Diagnostic Systems
Laboratories, Webster, TX, USA) or the Beckman Coulter
UniCel DxI 800 system or Access 2 (Beckman Coulter, Full-
erton, CA, USA).
To date, DIA has been assayed using an ELISA method;
however, this method is time consuming and requires con-
siderable labor, thereby resulting in a long turnaround time.
However, Beckman Coulter has launched a DIA product
that is used in conjunction with an automated chemilumi-
nescence analyzer, and Lambert-Messerlian et al. [9] re-
cently published median values for DIA using the Beckman
Coulter Access immunoassay system in 570 women of Euro-
pean descent. We established the gestational age-specific
second-trimester median values for each marker of the
quadruple test in Korean second-trimester pregnant women
using the Beckman Coulter UniCel DxI 800 immunoassay
system in order to make it applicable for use in the Kore-
an population. In addition, we compared the results of the
test for each marker using the UniCel DxI 800 system with
those obtained using either the Immulite 2000 assay (Sie-
mens Healthcare Diagnostics, Deerfield, IL, USA) or ELISA.
MATERIALS AND METHODS
We recruited 788 pregnant Korean women at 15 to 20
weeks gestation who visited the clinics of Yonsei Univer-
sity Health System, or the clinics that refer the quadruple
test to Seoul Clinical Laboratories for prenatal checkups.
We stored serum samples from each patient in a deep freez-
er at -70℃ after completion of the requested quadruple
marker tests using the Immulite 2000 assay or ELISA, and
subsequently used these samples for the measurement of
beta-hCG, AFP, uE3, and DIA using the UniCel DxI 800
system.
Test imprecision was evaluated by following NCCLS EP
5-A guidelines and using commercially available quality
control materials (Lyphocheck Maternal Serum Control
Levels 1, 2, and 3, Bio-Rad, Irvine, CA, USA) for 5 days.
The median values for each of the four markers were
calculated using Benetech PRA (Benetech Clinical Software
Solutions, Toronto, Canada), using serum samples from
women with singleton pregnancies. The quadruple marker
serum screening was conducted at Gangnam Severance
Hospital (formerly Yongdong Severance Hospital, renamed
in March 2009), Yonsei University (Seoul, Korea), and Seoul
Clinical Laboratories, an independent medical laboratory.
We used the completed week for gestational age estimation.
Exclusion criteria for the subjects were as follows: 1) age
less than 18 yr, 2) those achieving pregnancy by assisted
reproductive technologies, 3) gestational age estimated
only by non-ultrasound methods (e.g., LMP), and 4) eth-
nic origin other than Korean. This study was approved by
the institutional review board of the Gangnam Severance
Hospital, where a triple marker test was initiated in 1995
and a quadruple marker test has been available since 2007.
The clinical laboratory of Gangnam Severance hospital cov-
ers three hospitals (Severance Hospital, Gangnam Sever-
ance Hospital, and Yongin Severance Hospital) of the Yon-
sei University Health System.
Quadruple tests (AFP, uE3, hCG, DIA) were conducted
using the UniCel DxI 800 system (Beckman Coulter), and
the AFP, uE3, and hCG values were compared with the val-
ues determined using the Immulite 2000 assay. In addition,
DIA results were compared with those obtained by ELISA
using 442 stored samples.
Passing-Bablok linear regressions, Spearman correlations,
Abbreviations: AFP, alpha-fetoprotein; uE3, unconjugated estriol; hCG,
human chorionic gonadotrophin; DIA, dimeric inhibin A.
Sample Level Mean
Within-run Total
CV (%)
AFP (ng/mL) Low 9.94 3.36 4.45
Middle 30.14 4.25 4.14
High 76.21 3.84 3.84
uE3 (ng/mL) Low 0.46 5.85 5.77
Middle 1.45 3.02 2.79
High 4.61 4.05 4.50
Beta-hCG (IU/mL) Low 7,955 2.30 2.12
Middle 24,300 5.39 5.07
High 51,426 3.73 4.81
DIA (pg/mL) Low 150.4 3.91 3.88
Middle 390.4 5.23 5.83
High 802.9 5.27 5.36
Table 1. Precision of the Beckman Coulter DxI for the quadruple
assay
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and Bland-Altman plots were generated using Analyse-It
software version 1.71 (Leeds, UK).
RESULTS
Total coefficients of variation (CV) were estimated accord-
ing to CLSI Guideline EP5-A2 [10] and the results ranged
from 2.1% to 5.8% for low, from 2.8% to 5.8% for middle,
and from 3.8% to 5.4% for high variation (Table 1).
Method comparisons were performed using Passing-Ba-
blok regression and Bland-Altman plots. Passing-Bablok
regression produced variable slopes ranging from 0.28 to
1.22, and Spearman correlation coefficients ranged from
0.833 to 0.944 (Fig. 1). The Bland-Altman plot demonstrates
with average bias for each test with the 95% confidence
interval in parentheses were as follows: AFP, 10.7% (-13.7%
to 35.2%); uE3, -91.1% (-125.1% to -57.0%); hCG, 10.8%
(-19.6% to 41.2%); DIA, -8.0% (-53.7% to 37.8%) (Fig. 2).
Fig. 1. Comparison study of each of the four tests of the quadruple marker by DxI vs Immulite or DSL ELISA. (A) AFP, (B) uE3, (C) hCG,
(D) DIA.
Abbreviations: DXI, UniCel DxI 800 (Beckman Coulter, Fullerton, CA, USA); Immulite, Immulite 2000 (Siemens Healthcare Diagnostics, Deer-
field, IL, USA); DSL ELISA (DSL, Webster, TX, USA); AFP, alpha-fetoprotein; uE3, unconjugated estriol; hCG, human chorionic gonadotro-
phin; DIA, dimeric inhibin A (DIA).
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The median values for each of the four markers at 15-20
weeks of gestations are presented in Table 2.
DISCUSSION
All quadruple test assays conducted using the UniCel
DxI 800 immunoassay system yielded results comparable
with those obtained using the Immulite 2000 assay or ELISA,
but with significant bias, thus necessitating the calcula-
tion of median values for prenatal risk estimation. The
number of 19th week subjects was slightly less than the
recommended number of 100 and there were only 17 sub-
jects in the 20th week. However, the number of subjects
in the 15th to the 18th gestational weeks was sufficient for
regression analysis of the results for each marker. The me-
dian values of DIA in these Korean samples appeared to be
higher than those in Western samples [9] (Table 3).
Rawlins et al. [11] reported that DIA Access and ELISA
Passing-Bablok analysis yielded a slope of 0.88 (95% con-
fidence interval [CI], 0.85 to 0.91), an intercept of -3.67
(95% CI, -16.26 to 6.09), an r value of 0.980, and a Bland-
Altman analysis mean percentage difference of -14.6%. We
Fig. 2. Bland-Altman plots for each of the four markers in the quadruple test using Unicel DxI 800 vs Immulite 2000 or DSL ELISA. (A) AFP,
(B) uE3, (C) hCG, (D) DIA.
Abbreviations: See Fig. 1.
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confirmed similar biases and correlations. Lambert-Messer-
lian et al. [9] reported a slope of 1.001 (95% CI, 0.998 to
1.004) and an intercept of -0.776 (95% CI, -3.112 to 1.560)
(Table 4). The UniCel DxI 800 system incorporates an ana-
lyzer that is essentially the same as that used in the Access
2 system manufactured by the same company, except that
the former is like the integration of four units of the lat-
ter. Although we do not know the exact reasons why our
results differ slightly from the previous studies [9, 11], we
suspect that a difference in instrument (UniCel DxI 800
instead of Access) or random error, particularly in ELISA,
could be the reasons for the difference. Beckman Coulter
claim that there have been no calibrator changes in recent
years.
DIA precision (within-run CV, 3.9-5.3%; total CV, 3.9-
5.4%) in our study was similar to that of Rawlins et al. [11]
(within-run CV, 3.2-3.6%; total CV, 4.1-4.2%) for similar
levels (Table 1). The precision seemed to be better than that
reported by Erickson et al. [12] (6.4-8.9%) using the ELISA
method.
We compared triple marker data with the data from sam-
ples collected in other countries in a study that used the
same Beckman Coulter analyzers-Access 2 or UniCel DxI
800 [13] (Table 5-7). The medians of AFP and hCG levels
*Beckman Coulter Access.
Abbreviation: NE, not evaluated.
Study N Slope Intercept r
Mean
% dif-
ference
Mean ratio
of the two
assays
Lambert-Messer- 565 1.00 -0.776 0.960 NE 0.768
lian et al.* [9]
Rawlins et al.* [11] 119 0.88 -3.67 0.980 -14.6% NE
Present study 447 0.86 14.88 0.834 -8.0% 0.949
Table 4. Comparison of dimeric inhibin A (DIA) between auto-
mated assay and ELISA
*Completed gestational week as determined by ultrasound; �Regression equations used were derived using Benetech software as follows: Median
AFP=10(0.05874×wk+0.69234); Median uE3=10(0.09983×wk-1.61100); Median hCG=21.66705+54.07473×e-0.53946×(wk-14); and Median DIA=10 (0.02002×wk2-0.70594×wk+8.47311).
Abbreviations: AFP, alpha-fetoprotein; uE3, unconjugated estriol; hCG, human chorionic gonadotrophin; DIA, dimeric inhibin A; Obs, observed medi-
an values; Reg, regressed median values.
Gestational
week*
N. of
samples
AFP (ng/mL) uE3 (ng/mL) hCG (IU/mL) DIA (pg/mL)
Obs Reg� Obs Reg Obs Reg Obs Reg
15th 130 40.9 39.7 0.8 0.9 46.2 46.7 222.4 222.3
16th 219 44.1 45.4 1.1 1.1 37.4 36.3 188.0 190.0
17th 160 53.4 52.0 1.4 1.4 28.7 30.2 185.3 178.1
18th 165 58.8 59.6 1.7 1.7 25.9 26.6 176.8 183.0
19th 97 67.0 68.2 2.0 2.1 26.6 24.6 209.2 206.3
20th 17 89.1 78.1 2.8 2.7 21.1 23.4 258.9 254.9
Total 788
Table 2. Median values of each of the four quadruple markers determined using the Beckman Coulter DxI
*Completed gestational week as determined by ultrasound; �Beckman Coulter Access; �Log-linear regression; �Median MoM=10 to the power (slope*
weight+intercept), slope=-0.00175, intercept=0.22616.
Gestational
week*
Lambert-Messerlian et al.�[9] Rawlins et al.�[11] Present study
N Observed Regressed N Observed N Observed Regressed�
Maternal weight-
corrected values�
15th 82 157.3 147.0 2,422 166 130 222.4 222.3 225.9
16th 126 126.0 138.6 3,897 149 219 188.0 190.0 195.4
17th 106 134.3 135.0 2,851 150 160 185.3 178.1 187.2
18th 103 142.1 136.5 1,079 151 165 176.8 183.0 178.8
19th 90 147.4 143.0 526 161 97 209.2 206.3 206.2
20th 58 144.4 155.4 279 174 17 258.9 254.9 277.7
Total 565 11,054 788
Table 3. Comparison of the median values (pg/mL) of dimeric inhibin A
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in Koreans appear to be somewhat higher, although the
uE3 levels appear to be similar. Crandall et al. [14] noted
somewhat higher AFP concentrations in Asian samples.
Bogart et al. [15] noted possibly higher hCG concentrations in
Asian samples. uE3 concentrations have been reported to
be similar in samples of European and African descent, but
have not been reported for Asians [16]. Our study showed
similar median values for uE3. Benn et al. [17] postulated
that the differences observed in the various studies may
be attributable to the inconsistent use of maternal weight
correction, heterogeneity in the gestational ages of the
screened populations, maternal age differences, and regional
differences in the subpopulations of women included in each
group.
In addition, Benn et al. [18] and Serdar et al. [19] report-
ed that analytical variations have a great impact on second
trimester risk estimation procedures and some articles have
reported borderline cases as being problematic [18, 20]. A
survey report of external quality control samples for 9 clini-
cal laboratories in Korea showed variable results for the
borderline cases that necessitated standardization [21].
An automated platform for quadruple screening has sev-
eral advantages over manual ELISA, namely, better preci-
sion (3.9-5.8% vs 6.1-7.8%), faster turnaround time (1 hr
vs 5 hr), and random access function vs batch mode in terms
of DIA.
*Completed gestational week as determined by ultrasound; �Median values of this study were converted to IU/mL from ng/mL by multiplying by 0.826
for the comparison; �Median values corrected for maternal weight using log-linear regression, Median MoM=10 to the power (slope*weight+intercept),
slope=-0.00236, intercept=0.29407.
Gestational
week*
Belgium Canada Germany UK USA Korea� Weight-corrected�
AFP (IU/mL)
Vranken et al. [13] Present study
14th 22.1 - 21.8 23.6 - - -
15th 25.8 27.5 25.3 27.0 25.7 32.8 31.9 
16th 30.2 31.1 29.2 30.8 29.7 37.5 38.2 
17th 35.3 35.1 32.5 35.2 34.4 43.0 43.8 
18th 41.2 39.7 37.5 40.2 39.7 49.2 49.8 
19th 48.2 44.9 46.3 46.0 46.0 56.3 55.8 
20th - 50.6 - 52.5 53.2 64.5 78.0 
Table 5. Regressed median values of alpha-fetoprotein (AFP) compared with those of samples from other countries
*Completed gestational week determined by ultrasound; �Median val-
ues of this study were converted to nmol/L from ng/mL by multiplying by
3.47 for the comparison; �Median values corrected for maternal weight
using log-linear regression, Median MoM=10 to the power (slope*wei-
ght+intercept), slope=-0.00061, intercept=0.09007.
uE3 (nmol/L)
Gesta-
tional
week*
Vranken et al. [13] Present study�
Belgium Canada Germany UK Korea
Weight-
corrected�
14th 2.15 - 2.22 2.26 - -
15th 2.80 2.53 3.02 2.84 3.12 2.93 
16th 3.66 3.19 3.92 3.58 3.82 3.81 
17th 4.77 3.99 5.00 4.51 4.86 4.87 
18th 6.22 4.96 6.21 5.67 5.90 5.92 
19th 8.11 6.21 7.95 7.14 7.29 6.99 
20th - 7.77 - 8.99 9.37 10.00 
Table 6. Regressed median values of uE3 compared with those
of samples from other countries
*Completed gestational week determined by ultrasound;�Median val-
ues corrected for maternal weight using log-linear regression, Median
MoM=10 to the power (slope*weight+intercept), slope=-0.00258, inter-
cept=0.29094.
hCG (IU/mL)
Gesta-
tional
week*
Vranken et al. [13] Present study
Belgium Canada Germany UK Korea
Weight-
corrected�
14th 37.3 - 34.9 40.0 - -
15th 30.2 42.4 26.5 33.2 46.7 43.9 
16th 24.5 34.1 21.4 27.6 36.3 35.6 
17th 19.9 28.3 18.9 22.9 30.2 26.6 
18th 16.1 24.1 17.3 19.1 26.6 23.4 
19th 13.0 21.2 14.8 15.9 24.6 23.2 
20th - 19.1 - 13.2 23.4 19.6
Table 7. Regressed median values of human chorionic gona-
dotrophin (hCG) compared with those of samples from other
countries
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In conclusion, quadruple test assays conducted using the
UniCel DxI 800 system yielded results comparable to those
obtained using the Immulite 2000 assay, but with signifi-
cant bias, thus necessitating the calculation of median val-
ues. We established median values for each week of ges-
tation (15 to 20 weeks) for each marker in Korean women.
REFERENCES
1. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard
T, et al. Maternal serum screening for Down’s syndrome in early
pregnancy. BMJ 1988;297:883-7.
2. Egan JF, Kaminsky LM, DeRoche ME, Barsoom MJ, Borgida AF,
Benn PA. Antenatal Down syndrome screening in the United States
in 2001: a survey of maternal-fetal medicine specialists. Am J Obstet
Gynecol 2002;187:1230-4.
3. Kim JM, Sim AS, Lee EH. Amniotic chromosomal analysis in preg-
nant women identified by triple-marker testing as screen positive.
Korean J Lab Med 2006;26:123-30.
4. Kim SK, Bai SW, Chung JE, Jung YN, Park KH, Cho DJ, et al. Triple
marker screening for fetal chromosomal abnormalities in Korean
women of advanced maternal age. Yonsei Med J 2001;42:199-203.
5. Han SH, An JW, Jeong GY, Yoon HR, Lee A, Yang YH, et al. Clini-
cal and cytogenetic findings on 31,615 mid-trimester amniocenteses.
Korean J Lab Med 2008;28:378-85.
6. Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined
second-trimester biochemical and ultrasound screening for Down
syndrome. Obstet Gynecol 2002;100:1168-76.
7. Benn PA, Fang M, Egan JF, Horne D, Collins R. Incorporation of
inhibin-A in second-trimester screening for Down syndrome. Obstet
Gynecol 2003;101:451-4.
8. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. SURUSS in per-
spective. Semin Perinatol 2005;29:225-35.
9. Lambert-Messerlian GM, Palomaki GE, Canick JA. Inhibin A mea-
surement using an automated assay platform. Prenat Diagn 2008;
28:399-403.
10. National Committee for Clinical Laboratory Standards. Evaluation
of precision performance of quantitative measurement methods:
approved guideline. NCCLS document EP5-A2. 2nd ed. Wayne,
PA: NCCLS, 2004.
11. Rawlins ML, La’ulu SL, Erickson JA, Roberts WL. Performance char-
acteristics of the Access Inhibin A assay. Clin Chim Acta 2008;397:
32-5.
12. Erickson JA, Ashwood ER, Gin CA. Evaluation of a dimeric inhib-
in-A assay for assessing fetal Down syndrome: establishment, com-
parison, and monitoring of median concentrations for normal preg-
nancies. Arch Pathol Lab Med 2004;128:415-20.
13. Vranken G, Reynolds T, Van Nueten J. Medians for second-trimester
maternal serum markers: geographical differences and variation
caused by median multiples-of-median equations. J Clin Pathol 2006;
59:639-44.
14. Crandall BF, Lebherz TB, Schroth PC, Matsumoto M. Alpha-feto-
protein concentrations in maternal serum: relation to race and body
weight. Clin Chem 1983;29:531-3.
15. Bogart MH, Jones OW, Felder RA, Best RG, Bradley L, Butts W, et
al. Prospective evaluation of maternal serum human chorionic gona-
dotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165:
663-7.
16. Simpson JL, Elias S, Morgan CD, Shulman L, Umstot E, Andersen
RN. Second trimester maternal serum human chorionic gonado-
tropin and unconjugated oestriol levels in blacks and whites. Lancet
1990;335:1459-60.
17. Benn PA, Clive JM, Collins R. Medians for second-trimester mater-
nal serum alpha-fetoprotein, human chorionic gonadotropin, and
unconjugated estriol; differences between races or ethnic groups.
Clin Chem 1997;43:333-7.
18. Benn PA and Collins R. Evaluation of effect of analytical impreci-
sion in maternal serum screening for Down’s syndrome. Ann Clin
Biochem 2001;38:28-36.
19. Serdar MA, Tutuncu L, Olgun A, Hasimi A, Ozgurtas T, Erbil MK.
The effects of analytical factors on second trimester risk estimations.
Int J Gynaecol Obstet 2006;93:28-32.
20. Wald NJ, Bestwick JP, Huttly WJ, Morris JK, George LM. Validation
plots in antenatal screening for Down’s syndrome. J Med Screen
2006;13:166-71.
21. Kim S, Kim YH, Min WK. Prenatal serum marker screening in Korea:
survey results. Korean J Lab Med 2007;27:28-33.
